Mounjaro hits India, Bengal's Diamond Harbour Model, and Waqf Bill faces heat
3 Things
Intro
This chapter covers the launch of the weight loss drug Mounjaro in India, highlighting its unique mechanisms and advantages over competitors like Ozempic. It also examines potential side effects and the broader implications for obesity treatment.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
